/Companies

Tricida

South San Francisco, US · Founded 2013 · Delaware corporation · 7 known investors

Find your way into Tricida

Sign up to see every warm intro you have to Tricida

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Tricida team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

Tricida was founded in 2013 by Gerrit Klaerner.

GK
Gerrit KlaernerFounder
MM
Melissa MikschExecutive

Board

SC
Sandra CoufalBoard director
DBDavid Bonita
David BonitaBoard directorGeneral Partner at OrbiMed
KVKlaus Veitinger
Klaus VeitingerBoard directorVenture Partner at OrbiMed
RA
Robert AlpernBoard director

Investors · 7

Also in the syndicate · 1

Deep Track Capitallead

Reported raises · per SEC filings

Form D private placements

$103.1M disclosed across 4 of 5 rounds · 2013–2021

▶$57.6MraisedNov 2017 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Edward HejlekExecutive Officer
  • Klaus VeitingerDirector
  • Gerrit KlaernerExecutive Officer, Director
  • David HirschDirector
  • Jerry BuysseExecutive Officer
  • Robert AlpernDirector
  • Sandra CoufalDirector
  • David BonitaDirector
  • Wilhelm StahlExecutive Officer
  • Claire LockeyExecutive Officer
  • Geoffrey ParkerExecutive Officer
Offering amount
$57.6M
Amount sold
$57.6M
First sale
Nov 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$23.9MraisedJul 2016 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David BonitaDirector
  • David HirschDirector
  • Klaus VeitingerDirector
  • Robert AlpernDirector
  • Sandra CoufalDirector
  • Claire LockeyExecutive Officer
  • Gerrit KlaernerExecutive Officer, Director
  • Jerry BuysseExecutive Officer
  • Edward HejlekExecutive Officer
Offering amount
$55.5M
Amount sold
$23.9M
First sale
Jul 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.1MraisedFeb 2015 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Sandra CoufalDirector
  • Melissa MikschExecutive Officer
  • David BonitaDirector
  • Robert AlpernDirector
  • Klaus VeitingerDirector
  • Gerrit KlaernerExecutive Officer, Director
Offering amount
$30.3M
Amount sold
$17.1M
First sale
Feb 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedJan 2014 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Sandra CoufalDirector
  • Robert AlpernDirector
  • Gerrit KlaernerExecutive Officer, Director
  • Melissa MikschExecutive Officer
Offering amount
$13.2M
Amount sold
$4.5M
First sale
Dec 2013
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who founded Tricida?
Tricida was founded by Gerrit Klaerner in 2013.
Who are Tricida's investors?
Tricida's investors include Avoro Capital Advisors, Longitude Capital, Wellington Management, Frazier Life Sciences, Hercules Capital, Inc., OrbiMed.
How much funding has Tricida raised?
Tricida has disclosed $103.1M raised across 4 of its 5 known rounds.
Where is Tricida headquartered?
Tricida is headquartered in South San Francisco, US.